Epigral Announcements
Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on 25.11.2025.
21 Nov, 2025 | 11:12am • Source: BSE
Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025
17 Nov, 2025 | 10:34am • Source: NSE
Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025.
17 Nov, 2025 | 10:27am • Source: BSE
Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025.
17 Nov, 2025 | 10:27am • Source: BSE
Epigral Limited submits copy of Newspaper Publication pertaining to Un-Audited Financial Results - 30.09.2025
12 Nov, 2025 | 10:51am • Source: BSE
Epigral Limited submits Audio Recording of Conference Call discussing Q2 FY2026 Results.
10 Nov, 2025 | 09:22pm • Source: BSE
Epigral Limited has informed the Exchange regarding Appointment of MR. RAKESH AGRAWAL as Chief Financial Officer of the company w.e.f. November 10, 2025
10 Nov, 2025 | 01:51pm • Source: NSE
Epigral Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Press Release on Un-Audited Financial Results Q2 FY26
10 Nov, 2025 | 01:48pm • Source: NSE
UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025.
10 Nov, 2025 | 01:46pm • Source: BSE
UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025.
10 Nov, 2025 | 01:46pm • Source: BSE
Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. 10.11.2025.
10 Nov, 2025 | 01:42pm • Source: BSE
Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. 10.11.2025.
10 Nov, 2025 | 01:42pm • Source: BSE
Investor Presentation on Un-Audited Financial Results - Q2 FY26.
10 Nov, 2025 | 01:37pm • Source: BSE
Press Release on Un-Audited Financial Results Q2-FY26.
10 Nov, 2025 | 01:35pm • Source: BSE
1. Approved Un-Audited (Standalone & Consolidated) Financial Results of the Company for theSecond Quarter and Half Year ended on 30th September, 2025; and took on...
10 Nov, 2025 | 01:22pm • Source: BSE
Epigral Limited has informed the Exchange about Conference Call on Monday, 10th November, 2025 to discuss Q2 FY26 Results.
05 Nov, 2025 | 06:08pm • Source: BSE
Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve...
04 Nov, 2025 | 11:24am • Source: BSE
CERTIFICATE U/R 74(5) OF SEBI (DP) REGULATIONS.
13 Oct, 2025 | 01:49pm • Source: BSE
Notice of closure of Trading Window w.e.f. 01.10.2025.
27 Sep, 2025 | 11:21am • Source: BSE
Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investors / Analysts on 26.09.2025, 27.09.2025 and 30.09.2025.
25 Sep, 2025 | 05:21pm • Source: BSE